Scientist to Watch

» ecology, structural biology and cancer

Most Recent

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Instructor, Department of Systems Biology, University of Texas MD Anderson Cancer Center. Age: 38

1 Comment

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: Mary O’Connor: Warming Up

Mary O’Connor: Warming Up

By | June 1, 2013

Assistant Professor, Department of Zoology, University of British Columbia. Age: 34

1 Comment

image: Emily Scott: Enzyme Explorer

Emily Scott: Enzyme Explorer

By | March 1, 2013

Associate Professor, Medicinal Chemistry, University of Kansas. Age: 43

0 Comments

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Lynne-Marie Postovit: Cancer Modeler

Lynne-Marie Postovit: Cancer Modeler

By | January 1, 2012

Assistant Professor, Department of Anatomy and Cell Biology, University of Western Ontario. Age: 34

3 Comments

image: Seirian Sumner: Wasp Whisperer

Seirian Sumner: Wasp Whisperer

By | August 1, 2011

Research Fellow, Institute of Zoology, London. Age: 37

0 Comments

image: Andrew Carter: Dynein Trailblazer

Andrew Carter: Dynein Trailblazer

By | May 25, 2011

Group Leader, Laboratory of Molecular Biology, Medical Research Council. Age: 36

0 Comments

image: Kelly Benoit-Bird: Sounding the Deep

Kelly Benoit-Bird: Sounding the Deep

By | April 1, 2011

Associate professor, College of Oceanic and Atmospheric Sciences, Oregon State University. Age: 34

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham